FUCILI, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 1.301
EU - Europa 303
AS - Asia 297
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.905
Nazione #
US - Stati Uniti d'America 1.298
CN - Cina 141
SG - Singapore 99
IT - Italia 70
UA - Ucraina 68
DE - Germania 57
PL - Polonia 34
TR - Turchia 34
FI - Finlandia 23
GB - Regno Unito 22
SE - Svezia 16
ID - Indonesia 9
IN - India 8
HK - Hong Kong 5
BE - Belgio 2
LT - Lituania 2
MX - Messico 2
RU - Federazione Russa 2
AL - Albania 1
AT - Austria 1
AU - Australia 1
BR - Brasile 1
CA - Canada 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
GR - Grecia 1
LU - Lussemburgo 1
NL - Olanda 1
RO - Romania 1
VN - Vietnam 1
Totale 1.905
Città #
Woodbridge 169
Fairfield 127
Chandler 108
Ashburn 107
Santa Clara 92
Houston 84
Jacksonville 76
Singapore 72
Cambridge 55
Wilmington 55
Seattle 53
Beijing 47
Ann Arbor 35
Warsaw 34
Izmir 25
Bremen 21
Milan 21
Princeton 21
Shanghai 21
Los Angeles 19
New York 19
Nanjing 18
Boardman 13
Ferrara 12
Helsinki 9
Jakarta 9
Washington 9
Nanchang 6
Chicago 5
Leawood 5
San Diego 5
Shenyang 5
Auburn Hills 4
Changsha 4
Falls Church 4
Hebei 4
Hong Kong 4
Augusta 3
Hangzhou 3
Monmouth Junction 3
Redmond 3
Redwood City 3
Tappahannock 3
Addison 2
Almenno San Bartolomeo 2
Bologna 2
Brussels 2
Frankfurt am Main 2
Lanzhou 2
London 2
Mountain View 2
Munich 2
Norwalk 2
Palestrina 2
Taizhou 2
Zhengzhou 2
Baoding 1
Clearwater 1
Coatbridge 1
Collegeville 1
Dearborn 1
Falkenstein 1
Forest City 1
Gurgaon 1
Haikou 1
Hanoi 1
Hefei 1
Jiaxing 1
Jinan 1
Krasnodar 1
Las Vegas 1
Luxembourg 1
Mexico City 1
Ningde 1
Orange 1
Padova 1
Poncarale 1
Prescot 1
Pune 1
San Mateo 1
Santiago 1
Senhor do Bonfim 1
Tianjin 1
Tirana 1
Toronto 1
Vellore 1
Vienna 1
Walnut 1
Yellow Springs 1
Totale 1.454
Nome #
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 162
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 159
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 153
Incremental exercise using progressive versus constant pedaling rates: A study in cardlac patients 117
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure 108
null 94
Circulating stem cells vary with NYHA stage in heart failure patients 93
null 91
Neglected COPD and chronic comorbidities in elderly patients with chronic heart failure 90
null 86
ARNIs: balancing “the good and the bad” of neuroendocrine response to HF 85
The prospective impact of chronic obstructive pulmonary disease on short-term prognosis of patients with chronic heart failure 84
Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease. 84
Plasma soluble HLA-G levels in a cohort of heart failure patients exposed to chemicals 82
The utility of echocardiography in elderly smokers with COPD and of spirometry in elderly smokers with CHF. 72
Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure 71
Chronic obstructive pulmonary disease in heart failure: prevalence, therapeutic and prognostic implications. 64
Looking for a tailored therapy for heart failure: Are we capable of treating the patient instead of the disease? 44
Differential role of circulating microRNAs to track progression and pre-symptomatic stage of chronic heart failure: A pilot study 40
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD. 38
In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure 35
Diagnosis and treatment of cardiomyopathies: A paradigm shift and an evolutionary step forward in cardiology 33
Occurrence and impact of chronic obstructive pulmonary disease in elderly patients with stable heart failure. 32
Understanding the results of the PARAGON-HF trial 24
Totale 1.941
Categoria #
all - tutte 10.795
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.795


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020161 0 0 0 0 0 0 0 36 27 43 47 8
2020/2021284 22 37 23 24 17 33 6 31 10 32 40 9
2021/2022201 17 11 9 8 8 9 11 6 10 22 19 71
2022/2023267 22 7 23 27 53 30 22 25 36 1 10 11
2023/2024162 13 6 10 5 14 61 4 8 5 6 0 30
2024/2025270 9 33 41 15 73 74 11 14 0 0 0 0
Totale 1.941